Dipnarine Maharaj, MB, ChB, MD, FRCP (Glasgow), FRCP (Edinburgh), FRCPath, FACP

Dr. Dipnarine Maharaj is the Founder and Medical Director of the South Florida Bone Marrow Stem Cell Transplant Institute and its affiliate the Stem Cell Cryobank. Dr. Maharaj obtained his medical degree from the University of Glasgow Medical School, Scotland and completed his internship and residency in Internal Medicine and Hematology followed by specialist fellowship training in Hematology, Oncology and Bone Marrow Stem Cell Transplantation the University’s Glasgow Royal Infirmary, Scotland.

Dr. Maharaj worked with Alan Burnett, M.D., former Chairman of the United Kingdom Medical Research Council’s Acute Leukemia trials. Together they developed the first Scottish Bone Marrow/Stem Cell Transplant Program at the Royal Infirmary, Glasgow, Scotland. It was one of the first transplant centers to publish data on the use of autologous bone marrow transplantation for Acute Myeloid Leukemia and this is now a standard of care for the treatment of Leukemia.

Dr. Maharaj was subsequently responsible for the initiation and development of The Leukemia Unit at Darlington Memorial Hospital, England. He was then recruited to the University of Miami/Jackson Memorial Hospital/Sylvester Cancer Center and together with Dr. John Byrnes they established the Bone Marrow Stem Cell Transplant Program and performed the first transplant on a Hodgkin’s lymphoma patient in 1991.

Dr. Maharaj continued his innovative clinical and translational research with the development of the first Outpatient Bone Marrow Stem Cell Transplant Centers in Florida . He was recruited to Bethesda Memorial Hospital, Boynton Beach, Florida where he established the Bethesda Bone Marrow Stem Cell Transplant Center. In 2001, together with Dr. Jacqueline Gouvea, who trained at the Fred Hutchinson Cancer Research Center, established the South Florida Bone Marrow Stem Cell Transplant Institute achieving Joint Commission Accreditation, American Association of Blood Bank Accreditation and Registration with the United States Food and Drug Administration. The Institute has an International reputation.

As an expert in stem cells Dr. Maharaj has conducted research regarding adult stem cell therapies and their impact on the immune system in the treatment of Blood Disorders, Cancers and Chronic Diseases. Dr. Maharaj has performed stem cell/bone marrow transplants for patients with leukemia, other cancers such as lymphomas and multiple myeloma and blood disorders. Those patients have achieved long term survival because of immune regeneration from their own adult bone marrow stem cells. More recently, Dr. Maharaj has been advocating for the collection and storage of one’s healthy adult stem cells for use in personalized health care in the future. He is also developing clinical protocols using the individual’s own stem cells for the treatment of chronic diseases such as diabetes, cardiac diseases and neurodegenerative disorders such as strokes, Parkinson’s disease, and Alzheimer’s disease. Dr. Maharaj has conducted research as the Principal onsite-Investigator for Immunex, Genentech, Amgen, Biomira, and Genzyme. Dr. Maharaj is the author of more than 80 published research papers and abstracts on bone marrow and stem cell transplantation for blood disorders, cancers, Parkinson’s disease, and other inflammatory diseases. He has also developed a new protocol for an education dedicated to excellence.

“I have seen the immense power of stem cells to repair diseased tissue and organs; I wish to share my experiences with you”
-Dr. Dipnarine Maharaj, MB, ChB, MD, FRCP(Glasgow), FRCP (Edinburg), FRCPath, FACP